Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumococcal Infections | 13 | 2025 | 281 | 4.990 |
Why?
|
| Streptococcus pneumoniae | 14 | 2025 | 389 | 4.550 |
Why?
|
| Pneumococcal Vaccines | 13 | 2024 | 174 | 3.340 |
Why?
|
| Serogroup | 6 | 2024 | 62 | 2.120 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2024 | 88 | 1.250 |
Why?
|
| Foreign Medical Graduates | 1 | 2024 | 10 | 0.850 |
Why?
|
| Pneumonia | 2 | 2024 | 341 | 0.780 |
Why?
|
| Pneumonia, Bacterial | 1 | 2024 | 78 | 0.760 |
Why?
|
| Vaccines, Conjugate | 3 | 2023 | 80 | 0.720 |
Why?
|
| Community-Acquired Infections | 1 | 2024 | 254 | 0.690 |
Why?
|
| Meningitis, Pneumococcal | 3 | 2019 | 42 | 0.690 |
Why?
|
| Hypersensitivity | 1 | 2024 | 227 | 0.670 |
Why?
|
| Meningitis, Bacterial | 2 | 2019 | 98 | 0.650 |
Why?
|
| Serotyping | 5 | 2018 | 170 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 9 | 2024 | 2596 | 0.580 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 157 | 0.570 |
Why?
|
| Vancomycin | 1 | 2019 | 226 | 0.510 |
Why?
|
| Asthma | 1 | 2024 | 922 | 0.460 |
Why?
|
| Pediatrics | 1 | 2024 | 1252 | 0.420 |
Why?
|
| Organ Transplantation | 1 | 2016 | 175 | 0.420 |
Why?
|
| Sinusitis | 1 | 2014 | 118 | 0.390 |
Why?
|
| Bartonella | 1 | 2012 | 10 | 0.370 |
Why?
|
| Bartonella Infections | 1 | 2012 | 7 | 0.370 |
Why?
|
| Infant | 10 | 2025 | 13352 | 0.350 |
Why?
|
| Child, Preschool | 8 | 2025 | 15110 | 0.340 |
Why?
|
| Endocarditis, Bacterial | 1 | 2012 | 128 | 0.330 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2019 | 859 | 0.330 |
Why?
|
| Child | 11 | 2024 | 26341 | 0.280 |
Why?
|
| Hospitalization | 1 | 2017 | 1950 | 0.270 |
Why?
|
| Humans | 23 | 2025 | 131163 | 0.270 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 1280 | 0.270 |
Why?
|
| Ceftriaxone | 2 | 2019 | 69 | 0.270 |
Why?
|
| Male | 15 | 2025 | 64957 | 0.240 |
Why?
|
| Adolescent | 8 | 2024 | 20987 | 0.230 |
Why?
|
| Missouri | 1 | 2025 | 42 | 0.230 |
Why?
|
| Infectious Disease Medicine | 1 | 2024 | 13 | 0.210 |
Why?
|
| Female | 14 | 2025 | 70963 | 0.210 |
Why?
|
| Carrier State | 1 | 2024 | 80 | 0.200 |
Why?
|
| Otitis Media | 1 | 2023 | 88 | 0.190 |
Why?
|
| Hospitals, Pediatric | 2 | 2018 | 808 | 0.190 |
Why?
|
| Antibodies, Bacterial | 3 | 2023 | 406 | 0.180 |
Why?
|
| Communicable Diseases | 1 | 2024 | 155 | 0.180 |
Why?
|
| United States | 5 | 2018 | 12072 | 0.180 |
Why?
|
| Prospective Studies | 4 | 2016 | 6459 | 0.180 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3829 | 0.170 |
Why?
|
| Vaccination | 2 | 2024 | 1060 | 0.170 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17753 | 0.160 |
Why?
|
| Medicine | 1 | 2022 | 101 | 0.160 |
Why?
|
| Bacteremia | 2 | 2016 | 446 | 0.160 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1889 | 0.160 |
Why?
|
| Immunocompromised Host | 2 | 2022 | 315 | 0.140 |
Why?
|
| Brucellosis | 2 | 2009 | 19 | 0.140 |
Why?
|
| Cephalosporins | 1 | 2019 | 135 | 0.140 |
Why?
|
| Pandemics | 1 | 2025 | 1118 | 0.130 |
Why?
|
| Incidence | 2 | 2016 | 3360 | 0.130 |
Why?
|
| Arthritis, Infectious | 1 | 2017 | 65 | 0.130 |
Why?
|
| Bacterial Capsules | 1 | 2016 | 42 | 0.120 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 63 | 0.120 |
Why?
|
| Immunization Schedule | 1 | 2016 | 111 | 0.120 |
Why?
|
| Penicillins | 1 | 2016 | 154 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1173 | 0.110 |
Why?
|
| Osteomyelitis | 1 | 2017 | 209 | 0.110 |
Why?
|
| Streptococcus | 1 | 2015 | 64 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2018 | 8635 | 0.100 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2013 | 25 | 0.100 |
Why?
|
| Utah | 1 | 2013 | 80 | 0.100 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2013 | 65 | 0.100 |
Why?
|
| Recurrence | 1 | 2016 | 1489 | 0.090 |
Why?
|
| Endoscopy | 1 | 2014 | 270 | 0.090 |
Why?
|
| Comorbidity | 1 | 2017 | 1595 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 2015 | 254 | 0.090 |
Why?
|
| Suburban Health | 1 | 2011 | 3 | 0.090 |
Why?
|
| Infant Welfare | 1 | 2011 | 25 | 0.090 |
Why?
|
| Uveitis | 2 | 2009 | 36 | 0.090 |
Why?
|
| Inappropriate Prescribing | 1 | 2011 | 40 | 0.090 |
Why?
|
| Social Responsibility | 1 | 2011 | 86 | 0.090 |
Why?
|
| Drug Resistance, Microbial | 1 | 2011 | 195 | 0.090 |
Why?
|
| Genotype | 1 | 2016 | 2595 | 0.080 |
Why?
|
| Sepsis | 1 | 2015 | 493 | 0.080 |
Why?
|
| Young Adult | 3 | 2015 | 10103 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2014 | 1246 | 0.080 |
Why?
|
| Physician's Role | 1 | 2011 | 164 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2016 | 5063 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 2701 | 0.080 |
Why?
|
| Aqueous Humor | 1 | 2009 | 16 | 0.070 |
Why?
|
| Brucella melitensis | 1 | 2009 | 8 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1447 | 0.070 |
Why?
|
| Health Promotion | 1 | 2011 | 422 | 0.070 |
Why?
|
| Critical Care | 1 | 2013 | 686 | 0.070 |
Why?
|
| Eye Diseases | 1 | 2008 | 107 | 0.060 |
Why?
|
| Peru | 3 | 2011 | 54 | 0.060 |
Why?
|
| Texas | 1 | 2014 | 3686 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2011 | 789 | 0.060 |
Why?
|
| Middle Aged | 3 | 2015 | 28601 | 0.040 |
Why?
|
| Adult | 3 | 2015 | 31282 | 0.030 |
Why?
|
| Aged | 1 | 2015 | 21025 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2022 | 722 | 0.030 |
Why?
|
| Twins | 1 | 2015 | 70 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 401 | 0.030 |
Why?
|
| Diarrhea, Infantile | 1 | 2011 | 31 | 0.020 |
Why?
|
| Common Cold | 1 | 2011 | 25 | 0.020 |
Why?
|
| Bronchitis | 1 | 2011 | 29 | 0.020 |
Why?
|
| Pharyngitis | 1 | 2011 | 34 | 0.020 |
Why?
|
| Dermatitis | 1 | 2011 | 28 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2011 | 164 | 0.020 |
Why?
|
| Agglutination Tests | 1 | 2009 | 8 | 0.020 |
Why?
|
| Panuveitis | 1 | 2008 | 3 | 0.020 |
Why?
|
| Blindness | 1 | 2008 | 70 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 342 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 786 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1239 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2085 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5196 | 0.010 |
Why?
|
OLARTE CARHUAZ's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(113)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_